Improvement in right ventricular strain with ambrisentan and tadalafil upfront therapy in scleroderma-associated pulmonary arterial hypertension

Valentina Mercurio, Monica Mukherjee, Ryan J. Tedford, Roham T. Zamanian, Rubina M. Khair, Takahiro Sato, Omar A. Minai, Fernando Torres, Reda E. Girgis, Kelly Chin, Rachel Damico, Todd M. Kolb, Stephen C. Mathai, Paul M. Hassoun

Research output: Contribution to journalLetter

10 Scopus citations
Original languageEnglish (US)
Pages (from-to)388-391
Number of pages4
JournalAmerican Journal of Respiratory and Critical Care Medicine
Volume197
Issue number3
StatePublished - Feb 1 2018

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine
  • Critical Care and Intensive Care Medicine

Cite this

Mercurio, V., Mukherjee, M., Tedford, R. J., Zamanian, R. T., Khair, R. M., Sato, T., Minai, O. A., Torres, F., Girgis, R. E., Chin, K., Damico, R., Kolb, T. M., Mathai, S. C., & Hassoun, P. M. (2018). Improvement in right ventricular strain with ambrisentan and tadalafil upfront therapy in scleroderma-associated pulmonary arterial hypertension. American Journal of Respiratory and Critical Care Medicine, 197(3), 388-391.